News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phylogeny, Inc. Shares in $1M Third Frontier Grant



6/28/2010 2:14:52 PM

COLUMBUS, Ohio--(BUSINESS WIRE)--Phylogeny, Inc., the in situ company, and Neoprobe have been awarded a $1M grant from the Ohio Third Frontier program. The grant will help accelerate the phase III clinical trial of Neoprobe’s radiopharmaceutical, Lymphoseek.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES